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Abstract
Aims Mesenchymal stromal cells isolated from different tissues are claimed to demonstrate similar therapeutic potential and
are often incorrectly named mesenchymal stem cells. However, through comparison of such cells is lacking. This study aimed
to compare the transcriptome of mesenchymal cells of the same phenotype isolated from the heart muscle and epicardial fat
of the same patient, before and after culture.
Methods and results Cells were isolated from biopsies of the right ventricle and epicardial fat collected from five patients
(three men and two women, mean age 59.4 ± 2.6) who underwent heart transplantation due to ischaemic cardiomyopathy.
In both tissues, immunophenotyping revealed three distinct populations: (i)CD31CD45CD90+CD34+CD146, (ii)
CD31CD45CD90+CD34CD146+, and (iii) CD31CD45CD90CD34CD146+, of which only the first one could be grown after
sorting. Material for RNA-seq was collected from these cells before culture (250 cells) and at passage 6 (5000 cells).
Transcriptomic analysis revealed that cells of the same phenotype (CD31CD45CD90+CD34+CD146) upon isolation prefer-
entially clustered according to the tissue of origin, not to the patient from whom they were isolated. Genes up-regulated in
the right ventricle-derived cells were related to muscle physiology while down-regulated genes included those encoding pro-
teins with transmembrane signalling receptor activity. After six passages, heart-derived and fat-derived cells did not acquire
similar transcriptome. Cells isolated from the right ventricle in comparison with their epicardial fat-derived counterparts dem-
onstrated higher level of transcripts related, among others, to RNA processing and muscle development. The down-regulated
genes were involved in the nucleosome assembly, DNA packaging and replication, and interleukin-7-mediated signalling path-
way. Cells from epicardial fat demonstrated higher heterogeneity both before and after culture. Cell culture significantly
changed gene expression profile within both tissues.
Conclusions This study is an essential indication that mesenchymal cells isolated from different tissues do not demonstrate
similar properties. Phenotypic identification and ease of isolation cannot be considered as a criterion in any therapeutic utili-
zation of such cells.
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Introduction
Mesenchymal stromal cells are described as plastic adherent
cells capable of differentiating in vitro into osteocytes,
chondrocytes, and adipocytes.1 Cells with such properties
can be isolated from various tissues and organs including
bone marrow, fat, the umbilical cord, and the heart, and they
have been claimed to demonstrate similar pro-angiogenic,
immunomodulatory, and anti-apoptotic paracrine activity.2,3
Thus, mesenchymal stromal cells were extensively investi-
gated in recent years as a novel therapeutic approach for
the regeneration of damaged tissues as well as in autoim-
mune diseases.2,4 Accordingly, the effect of bone marrow-
derived, fat-derived, and umbilical cord-derived cells adminis-
tration into damaged myocardium has already been assessed
in preclinical and clinical studies with the assumption that
ease of isolation of putative therapeutic cell population may
facilitate the development of successful treatment. This as-
sumption, however, was often made without taking into ac-
count that mesenchymal cells isolated from various tissues
may differ in terms of biological properties.1 Indeed,
Sacchetti et al. reported that cells derived from the bone
marrow, skeletal muscle, periosteum, and perinatal cord
blood demonstrating a set of cell surface markers considered
as characteristic for stromal cells in various tissues differed in
their gene expression profile and in vivo differentiation
capacity.5
Similarly, whole transcriptome analysis and surface marker
screening revealed that tissue of origin affects properties of
human bone marrow-derived, adipose-derived, and tonsil-
derived mesenchymal cells.6 These comparisons, however, fo-
cused on cells isolated from anatomically distant sites that
serve substantially different functions and were performed af-
ter in vitro cell expansion. Additionally, genetic variability of
patients from which distinct tissues were collected may influ-
ence the results. Thus, for a better understanding of mesen-
chymal stromal cell properties, a direct comparison of cells
isolated from distinct but anatomically close tissues derived
from the same individual, before and after cell culture, is
needed. This would also enhance our knowledge of the com-
ponents of connective tissue localized in different organs. Ac-
cordingly, we aimed to compare the transcriptome of
mesenchymal cells with the same immunophenotype isolated
from the right ventricle ofmyocardium and epicardial fat of the
same patient, upon isolation and after expansion in culture.
Methods
Patients’ characteristics
The investigation conforms with the principles outlined in the
Declaration of Helsinki, and all procedures were approved by
the Institutional Review Board and Bioethical Committee (KB/
430-62/13). Biopsies of the right ventricle and epicardial fat
were collected from the hearts of patients suffering from
ischaemic cardiomyopathy and undergoing heart transplanta-
tion surgery upon obtaining their informed consent. The
characteristics of patients from whom the material was col-
lected and used in this study are provided in Table 1.
Isolation of cells
Tissue biopsies were collected within 1 h after extraction of
heart from transplant recipients. Four pieces of myocardium
(approximately 2 cm × 2 cm × 2 cm each) lacking any signs
of myocardial lesions (scarring or fibrosis) were excised from
the right ventricle (free wall, mid-level, 30mm from the intra-
ventricular septum) and placed into cold Dulbecco’s Modified
Eagle’s medium (DMEM) with 4.5 g/L glucose (ThermoFisher
Scientific) supplemented with 10% fetal bovine serum (FBS,
ThermoFisher Scientific). Approximately 10 mL of epicardial
fat localized around ventricles and atria was excised and
transferred into cold DMEM with 4.5 g/L glucose supple-
mented with 10% FBS. Both tissues were subsequently
minced into small pieces. Fragments of myocardium were
washed with phosphate-buffered saline (PBS) supplemented
with 1% FBS (300 g, 1min) and suspended in NB4 collagenase
(Serva) solution (0.39 U/mL, dissolved in water containing
5 mM CaCl2 and 25 μg/mL DNase I (Roche), 5 mL of collage-
nase per 2 mL of tissue). After 1 h of digestion in 37°C, the
released cells were transferred into twice the volume of
DMEM F12 medium (Lonza) supplemented with 10% FBS
and centrifuged [300 g, 10min, room temperature (RT)]. Sub-
sequently, cells were suspended in 15 mL of DMEM F12 with
10% FBS and filtered through 70 μm strainer. Remaining tis-
sue fragments were further digested in the new collagenase
solution, and the released cells were collected as described
three additional times every 1 h (4 h of digestion in total). Cell
suspensions after each collection were pooled, centrifuged
(300 g, 10 min, RT), suspended in 15 mL of DMEM F12 with
10% FBS and filtered through 40 μm strainer.
Minced adipose tissue was washed twice with 20 mL of
PBS supplemented with 1% of FBS (300 g, 1 min, RT),
suspended in NB4 collagenase solution (0.39 U/mL, 5 mL of
collagenase per 2 mL of tissue), and digested for 1 h in 37°C
Table 1 Characteristics of patients enrolled in the study
Patient Age Sex Disease
1 60 M Ischaemic cardiomyopathy
2 56 F Ischaemic cardiomyopathy
3 63 M Ischaemic cardiomyopathy
4 58 M Ischaemic cardiomyopathy
5 60 F Ischaemic cardiomyopathy
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with shaking (200 rpm). Tissue suspension was additionally
vortexed every 15 min. Subsequently, the released cells were
transferred into twice the volume of DMEM F12medium sup-
plemented with 10% FBS (non-heat-inactivated) and centri-
fuged (300 g, 5 min, RT). Obtained pellet was vigorously
suspended in the supernatant and centrifuged again (300 g,
5 min, RT). The cell pellet was then washed with 20 mL PBS
with 1% FBS (300 g, 5 min, RT), suspended in 5 mL of PBS
with 1%), and filtered through 40 μm strainer.
Cell sorting and culture
Suspensions of cells isolated from the right ventricle and epi-
cardial fat were centrifuged (300 g, 10min, RT) and incubated
in 10 mL of red blood cells lysis buffer (1.5 M NH4Cl, 100 mM
NaHCO3, 10 mM EDTA, pH 7.4
7) (7 min, RT). Subsequently,
PBS was added to 50 mL, and cells were centrifuged (300 g,
10 min, RT), resuspended in 100 μL PBS with 1% FBS, and in-
cubated with the following set of mouse anti-human mono-
clonal antibodies (20 min, 4°C): anti-CD90-PE (20 μL,
Miltenyi Biotec), anti-CD34-APC (20 μL, Miltenyi Biotec),
anti-CD31-APC Cy7 (5 μL, BD Biosciences), anti-CD45-PE Cy7
(5 μL, BD Biosciences), and anti-CD146-FITC (5 μL, BD Biosci-
ences). Additionally, DAPI was used to discriminate live and
dead cells. Upon staining, cells were washed with PBS with
1% FBS, filtered through 40 μm strainer and subjected to cell
sorting on MoFlo XDP cell sorter (Beckman Coulter). From
each tissue, 250 cells of CD31CD45CD90+CD34+CD146
phenotype were directly sorted to 20 μL of 0.1% Triton
X-100 (Sigma-Aldrich) in nuclease-free water (Sigma-Aldrich)
containing 1 μL of recombinant ribonuclease inhibitor
(Sigma-Aldrich) and frozen in 80°C. All further sorted cells
of this phenotype were collected in IMDM medium (Lonza)
supplemented with 20% FBS, 10 ng/mL bFGF (PeproTech),
penicillin (100 U/mL, Sigma-Aldrich), and streptomycin
(100 μg/mL, Sigma-Aldrich) and seeded on a 48-well plate.
Cells were cultured in this medium until passage 6 when they
reached the number allowing for further steps. Cells were
then collected using Accutase (GE Healthcare), washed with
PBS, suspended in PBS with 1% FBS, and stained with DAPI.
Then, 5000 of live cells (DAPI negative) were sorted into RL
buffer of Single Cell Purification Kit (Norgen Biotek), and
RNA was isolated according to the protocol provided by the
manufacturer. RNA was eluted with 14 μL of water and fro-
zen in 80°C.
RNA-Seq analysis
Ion AmpliSeq Transcriptome Human Gene Expression Panel
(Thermo Fisher Scientific) was used for library preparation ac-
cording to the manufacturer’s protocol. Briefly, 50 ng of RNA
from culture samples or all RNA sample from primary cells
was reverse-transcribed, and the cDNA was subjected to mul-
tiplex PCR reactions to amplify fragments of the targeted
transcripts. The amplicons were then partially digested at
primer sequences followed by the adapters’ ligation to
amplicons and purification on AMPure XP beads (Beckman).
The created library was quantified on Bioanalyzer 2100 and
diluted to 80 pM before template preparation. Up to eight
barcoded libraries were subjected to automated template
preparation with Ion PI Hi-Q Chef Kit (Thermo) on the Ion
Chef Instrument (Thermo). Barcoded libraries samples were
sequenced using Ion PI Chip Kit v3 in Ion Proton (Thermo) ac-
cording to the manufacturer’s instructions. Raw RNA-Seq
reads were mapped to hg19 genome using with Ion Torrent
RNASeq Analysis plugin (version 5.0.3.0), which utilizes STAR8
as primary aligner and bowtie2 for remaining unaligned
reads.9 Reads corresponding to Homo sapiens genes were
counted with HTSeq count.10 Differential gene expression
was assessed with the DESeq2 R package.11 For the sake of
functional analysis, a gene was counted as differentially
expressed if its fold change absolute value was higher than
2 and adjusted P-value reported by DESeq2 was smaller than
0.05. Overrepresentation of genes associated with biological
processes (BP), described in gene ontology (GO) terms and
KEGG, was conducted with clusterProfiler12 package sepa-
rately for up-regulated and down-regulated genes. P-values
were corrected for multiple hypothesis testing using the
Benjamini–Hochberg procedure to control the FDR.13
Results
Upon isolation and staining with antibodies recognizing CD31,
CD34, CD45, CD90, and CD146 surface markers, three distinct
populations of cells were detected in the right ventricle
of myocardium and epicardial fat: (i) CD31CD45CD90+
CD34+CD146, (ii) CD31CD45CD90+CD34CD146+, and
(iii) CD31CD45CD90CD34CD146+ (Figure 1), from which
only the first could be cultured in used conditions and thus
was further subjected to RNA-seq analysis. Limited coverage
of transcriptome (851 transcripts) was obtained from 250
CD31CD45CD90+CD34+CD146 cells collected from the
right ventricle and epicardial fat upon isolation (Figure 2A).
Nevertheless, principal component analysis of detected tran-
scripts revealed that samples clustered according to the tis-
sue of origin rather than a patient from whom they were
derived (Figure 2B) what indicates that mesenchymal cells lo-
calized in the heart do not demonstrate a similar gene ex-
pression profile to their adipose tissue-derived counterparts.
Additionally, hierarchical clustering of differentially
expressed genes revealed a higher heterogeneity of cells iso-
lated from epicardial fat (Figure 2C). In a pairwise samples
comparison, three genes were up-regulated and 57 down-
regulated (adj. P-value <0.05) in the right ventricle-derived
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cells in comparison with their adipose tissue-derived counter-
parts. Because there were few significant differentiating
genes after correction for multiple hypotheses, we then used
the top 10% transcripts sorted according to a P-value as an in-
put for functional analyses with GO. For transcripts up-
regulated in the heart, this analysis yielded significant over-
representation of genes among GO terms belonging to 20
BP, one molecular function (MF), and seven cellular compo-
nent (CC) categories (adj. P-value <0.05; Table S1). The
down-regulated genes were enriched in none BP, two MF,
Figure 1 Immunophenotyping of freshly isolated cells from the right ventricle and epicardial fat. Representative gating strategy utilized to sort
CD9031CD45CD90+CD34+CD146 cells from the right ventricle and epicardial fat.
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and two CC categories. In general, the functional categories
with up-regulated genes were related to muscle physiology
while for down-regulated genes, these included genes
encoding proteins with transmembrane signalling receptor
activity (Table S1).
After expansion in culture, cells from both tissues dem-
onstrated mesenchymal-like morphology (data not shown).
However, immunophenotyping on passage 6 revealed that
they lost expression of CD34 marker and a lower percent-
age of cells expressed CD90 marker (Figure S1A,B). For fur-
ther evaluation of the impact of in vitro expansion on cells
characteristics, 5000 of live cells from the right ventricle
and epicardial fat were sorted and subjected to RNA-seq
analysis, providing substantial coverage of transcriptome
(Figure 3A). Principal component analysis of detected tran-
scripts revealed that upon culture samples again clustered
Figure 2 RNA-seq analysis of freshly isolated cells. (A) A number of transcripts detected in samples isolated from the right ventricle (HEARTS) and epi-
cardial fat (FAT). (B) Principal component analysis (PCA) of transcripts detected in cells isolated from both tissues. HEART:
CD31CD45CD90+CD34+CD146 cells isolated from the right ventricle (1, 2, 3, 4, 5—patient ID). FAT: CD31CD45CD90+CD34+CD146 cells isolated
from epicardial fat (1, 2, 4, 5—patient ID). (C) Hierarchical clustering based on differentially expressed transcripts detected in cells from both tissues.
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Figure 3 RNA-seq analysis of in vitro expanded cells (passage 6). (A) Number of transcripts detected in samples isolated from the right ventricle
(HEARTS) and epicardial fat (FAT). (B) Principal component analysis (PCA) of transcripts detected in cells isolated from both tissues. HEART:
CD31CD45CD90+CD34+CD146 cells isolated from right ventricle (1, 2, 3, 4, 5—patient ID). FAT: CD31CD45CD90+CD34+CD146 cells isolated
from epicardial fat (2, 3, 4, 5—patient ID). (C) Hierarchical clustering based on differentially expressed transcripts detected in cells from both tissues.
(D) Hierarchical clustering based on 40 most differentially expressed transcripts detected in cells from both tissues.
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Figure 4 Comparison of freshly isolated and in vitro expanded epicardial fat-derived cells. (A) Principal component analysis (PCA) of transcripts detected
in freshly isolated and in vitro expanded CD31CD45CD90+CD34+CD146 cells isolated from epicardial fat (FAT). Before: freshly isolated cells; after:
in vitro expanded cells (1, 2, 3, 4, 5—patient ID). (B) Gene ontology terms overrepresented among the genes differentiating (adj. P-value<0.05) freshly
isolated and in vitro expanded cells down-regulated after cell culture. (C) Gene ontology terms overrepresented among the genes differentiating (adj.
P-value <0.05) freshly isolated and in vitro expanded cells up-regulated after cell culture.
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Figure 5 Comparison of freshly isolated and in vitro expanded cells. (A) Principal component analysis (PCA) of transcripts detected in freshly isolated
and in vitro expanded CD31CD45CD90+CD34+CD146 cells isolated from the right ventricle (HEART). Before: freshly isolated cells; after: in vitro ex-
panded cells (1, 2, 3, 4, 5—patient ID). (B) Gene ontology terms overrepresented among the genes differentiating (adj. P-value <0.05) freshly isolated
and in vitro expanded cells down-regulated after cell culture. (C) Gene ontology terms overrepresented among the genes differentiating (adj. P-value
<0.05) freshly isolated and in vitro expanded cells up-regulated after cell culture.
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more according to the tissue of origin (Figure 3B) what in-
dicates that in vitro expansion does not unify gene expres-
sion profile of mesenchymal cells isolated from distinct
tissues. Additionally, hierarchical clustering of differentially
expressed transcripts showed higher heterogeneity of epi-
cardial fat-derived cells, as was also observed in samples
collected upon isolation, and revealed a set of genes up-
regulated explicitly in mesenchymal cells from the hearts
(Figure 3C,D). The functional analysis with GO using the
top 10% transcripts sorted according to a P-value assigned
transcripts up-regulated in the hearts to five BP, one MF,
and one CC category (adj. P-value <0.05; Table S2). These
terms were related to RNA processing and muscle develop-
ment. On the other hand, the down-regulated genes were
enriched in 27 BP, four MF, and four CC categories and
were involved in the nucleosome assembly, DNA packaging
and replication, and interleukin-7-mediated signalling path-
way (Table S2).
Importantly, principal component analysis of transcripts
detected both upon isolation and after in vitro expansion
revealed that cell culture substantially affects the tran-
scriptome of cells derived from investigated tissues (Fig-
ures 4 and 5). Interestingly, samples from epicardial fat
(Figure 4A) showed a high degree of heterogeneity both
before and after expansion, whereas their counterparts iso-
lated from right ventricle clustered close together at pas-
sage 6 (Figure 5A). Further GO analysis indicated that in
case of adipose tissue-derived cells in vitro culture signifi-
cantly down-regulated genes involved in, among others,
regulation of inflammatory response, protein activation cas-
cade, chemokine activity, sulfur compound binding, and gly-
cosaminoglycan binding (Table S3, Figure 4B) whereas it up-
regulated transcripts involved in, among others, cell mor-
phogenesis, protein autophosphorylation, cell junction orga-
nization, and cell adhesion molecule binding (Table S3,
Figure 4C). Within the heart-derived cells, on the other
hand, lower levels of transcripts involved in processes such
as regulation of heart contraction, regulation of vascular
development, complement activation, and positive regula-
tion of response to external stimulus were detected upon
expansion (Table S4, Figure 5B) concomitantly with a higher
expression of genes involved in, among others, chromatin
modification, double-strand break repair, and protein
serine/threonine kinase activity (Table S4, Figure 5C).
Discussion
The main finding of our study is the demonstration of signif-
icant differences in the transcriptome of mesenchymal cells
of the same phenotype isolated from two distinct tissues lo-
calized within one organ and the profound effect of in vitro
expansion on gene expression profile. We investigated the
components of the right ventricle and epicardial fat isolated
from the hearts of patients undergoing heart transplantation
as this model may further enhance our comprehension to
what extent the tissue of isolation shall be taken into account
in cell-based therapies. This is an important issue in preclini-
cal and clinical studies utilizing mesenchymal stromal cells.14
Accordingly, bona fide mesenchymal stem cells are localized
in the bone marrow within the haematopoietic niche, dem-
onstrate in vitro capacity for clonal growth and differentiation
into osteocytes, chondrocytes, and adipocytes, and reconsti-
tute bone marrow receptive for haematopoietic stem cells
engraftment upon in vivo administration.15
Nevertheless, cells of similar in vitro differentiation poten-
tial can be isolated from different tissues including more easily
accessible adipose tissue (e.g. collected during liposuction)
and therefore are similarly termed mesenchymal stem or stro-
mal cells.2 Such fat-derived cells are often used in preclinical
and clinical studies without thorough characterization. For in-
stance, a stromal vascular fraction obtained from liposuction-
collected adipose tissue was used in APOLLO clinical trial
targeting acute myocardial infarction; however, stromal vas-
cular fraction represents a crude and heterogeneous mix of
cell populations.16,17 Importantly, Sacchetti et al. already re-
ported that CD45CD34HLAIICD146+CD105+CD90+CD73+
cells capable of in vitro differentiation into osteocytes, adipo-
cytes, and chondrocytes isolated from the bone marrow, skel-
etal muscle, periosteum, and perinatal cord blood do not
demonstrate similar gene expression profile and in vivo biolog-
ical properties.5 Notably, only bone marrow-derived cells
formed bones with established haematopoietic environment
upon in vivo delivery whereas myogenic capacity was attrib-
uted to skeletal muscle-derived counterparts but not others.5
Similarly, distinct biological features were described for mes-
enchymal cells obtained from human embryonic stem cells, fe-
tal limb, and bone marrow even though they shared a
common phenotype.18 Thus, a comprehensive investigation
of any cell type is needed before considering its application
in cell-based therapy.
Interestingly, our immunophenotyping of cells isolated from
the right ventricle and epicardial fat revealed the presence of
three distinct populations differing in the expression of CD90,
CD34, and CD146 markers. As only CD31CD45CD90+
CD34+CD146 population could be expanded in vitro in the
culture conditions utilized in this study; we narrowed our
transcriptomic analysis to these cells. Nevertheless, further in-
vestigation of other observed cell types would be of impor-
tance for better characterization of various components of
connective tissue within one organ. Among them, CD31
CD45CD90+CD34CD146+ cells would most closely resemble
MSCs described by Sacchetti et al.; however, further studies
are needed to find optimal culture conditions for such popula-
tion isolated from heart and epicardial fat.5 Interestingly, CD34
was proposed to characterize MSCs in vitro, yet its expression
was lost upon expansion of cells investigated in this study.19,20
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The major strength of our study is the direct comparison
of mesenchymal cells isolated from distinct tissues of the
same patient. Such an approach limits the genetic variability
of different tissue donors (i.e. umbilical cord blood vs. bone
marrow or muscle in other studies5,6) and thus allows to fo-
cus on gene expression profile dependent on anatomical lo-
calization of cells. Indeed, the performed RNA-seq analysis
indicated that mesenchymal cells clustered according to
the tissue of origin rather than the patient from whom they
were isolated. Additionally, we describe a substantial impact
of cell culture on cellular transcriptome, which has not been
addressed in other studies.5,6,18 We believe that it should
be considered as an important factor for designing any
cell-based therapy. Finally, this study provides comprehen-
sive information on gene expression profile of mesenchymal
cells located in the heart, which may add to the under-
standing of the biological properties of cell populations
present in this organ, which is difficult to access for such
analysis.
However, we performed an analysis of cells derived from
diseased hearts, taken from patients undergoing transplant
surgery, which may not reflect the properties of mesenchy-
mal cells present in healthy cardiac tissues. Further studies
are also needed to evaluate whether cells isolated from dif-
ferent tissues within other organs demonstrate such sub-
stantial transcriptomic differences. Another limitation of
our study is the cell culture protocol (media, number of
passages, etc.), which may direct specific gene expression.
Last but not the least, limited transcriptome coverage in
the RNA-seq analysis of freshly isolated cells may narrow
the comparison of their transcriptomes to the highly
expressed genes.
Nevertheless, our findings revealed that cells expressing
the same mesenchymal markers isolated from tissues local-
ized within one organ have distinct transcriptomes. Thus,
ease of isolation shall not be primarily taken into account in
designing cell-based therapies. Instead, we believe that thor-
ough characterization, including transcriptomic and func-
tional studies, should stand behind further preclinical
evaluation of any cell type. High heterogeneity of adipose-
derived cells observed in our analysis additionally raises a
question on the efficacy of treatments based on mesenchy-
mal cells. Our data indicate that the mesenchymal cells of
various origin have different properties what undermines
the rationale for using them as cell therapy source in cardiac
diseases.
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Figure S1. Immunophenotyping of cells from the right ventri-
cle and epicardial fat on passage 6. A. Gating strategy for flow
cytometry analysis. B. The phenotype of cells isolated from
the right ventricle (HEART) and epicardial fat (FAT). Results
presented as mean ± SEM of a percentage of cells positive
for analysed markers from 5 patients enrolled in the study.
Red box – phenotype of initially isolated and sorted
population.
Table S1. Gene expression levels and Gene Ontology terms
and KEGG pathways overrepresented among the 10% genes
sorted according to a p. value in heart vs adipose primary
samples comparison. Individual sheets contain a list of GO
terms or KEGG pathways for upregulated (up) or downregu-
lated (down) genes;ID – GO or KEGG identifier, GeneRatio –
the ratio of number of differentiating genes in a given
term/pathway to the number of differentiating genes with
GO or KEGG identifier; BgRatio – the ratio of number of not
differentiating genes in a given term/pathway to the number
of expressed genes with GO or KEGG identifier; p-value -
p-value in hypergeometric test; q-value - p-value after FDR
correction; GeneID - list of genes assigned to a given
term/pathway; Count – number of differentiating genes con-
tributing to a given term/pathway; BP - biological processes
BP, MF - molecular function; CC - cellular component.
Table S2. Gene expression levels and Gene Ontology terms
and KEGG pathways overrepresented among the 10% genes
sorted according to a p. value in heart vs adipose cultured
samples comparison. Individual sheets contain a list of GO
terms or KEGG pathways for upregulated (up) or downregu-
lated (down) genes;ID – GO or KEGG identifier, GeneRatio –
the ratio of number of differentiating genes in a given
term/pathway to the number of differentiating genes with
GO or KEGG identifier; BgRatio – the ratio of number of not
differentiating genes in a given term/pathway to the number
of expressed genes with GO or KEGG identifier; p-value -
p-value in hypergeometric test; q-value - p-value after FDR
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correction; GeneID - list of genes assigned to a given
term/pathway; Count – number of differentiating genes con-
tributing to a given term/pathway; BP - biological processes
BP, MF - molecular function; CC - cellular component.
Table S3. Gene expression levels and Gene Ontology terms
overrepresented among the genes differentiating (adj.
p.value <0.05) primary and cultured adipose cells. Individual
sheets contain a list of GO terms for upregulated (up) or
downregulated (down) genes;ID – GO identifier, GeneRatio
– the ratio of number of differentiating genes in a given term
to the number of differentiating genes with GO identifier;
BgRatio – the ratio of number of not differentiating genes
in a given term to the number of expressed genes with GO
identifier; p-value - p-value in hypergeometric test; q-value -
p-value after FDR correction; GeneID - list of genes assigned
to a given term/pathway; Count – number of differentiating
genes contributing to a given term; BP - biological processes
BP, MF - molecular function; CC - cellular component.
Table S4. Gene expression levels and Gene Ontology terms
overrepresented among the genes differentiating (adj.
p.value <0.05) primary and cultured heart cells. Individual
sheets contain a list of GO terms for upregulated (up) or
downregulated (down) genes;ID – GO identifier, GeneRatio
– the ratio of number of differentiating genes in a given term
to the number of differentiating genes with GO identifier;
BgRatio – the ratio of number of not differentiating genes
in a given term to the number of expressed genes with GO
identifier; p-value - p-value in hypergeometric test; q-value -
p-value after FDR correction; GeneID - list of genes assigned
to a given term/pathway; Count – number of differentiating
genes contributing to a given term; BP - biological processes
BP, MF - molecular function; CC - cellular component.
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